Sydney, Australia –- Genetic Signatures Ltd has launched its prospectus offering institutional and retail investors the opportunity to invest in the exciting growing global molecular diagnostics market prior to the Company’s listing on the Australian Stock Exchange on 23 December 2014. Molecular diagnostics (MDx) is a modern technique increasingly used by hospitals and pathology labs […]
SAN DIEGO — Organovo Holdings, Inc. (NYSE MKT: ONVO) (“Organovo”), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today announced the full commercial release of the exVive3DTM Human Liver Tissue for preclinical drug discovery testing. Initially, clients will be able to access the technology through Organovo’s contract research services program. This model […]
Cambridge, UK — Horizon Discovery Group plc (LSE:HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced that its Horizon CombinatoRx division has been contracted by a top ten pharma company to profile a lead oncology asset. Under the terms of the agreement, Horizon CombinatoRx […]
BOTHELL, Wash. — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues (“BioLife” or the “Company”), today announced it has launched two new improved packaging options for its BloodStor and CryoStor cryopreservation freeze media […]
Limerick, PA. -– Rockland Immunochemicals Inc. today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Health (NIH). Rockland will use the grant to develop synthetic antibodies for detection and quantitation of modified RNAs. Also known as aptamers, synthetic antibodies can be used in basic […]
CAMBRIDGE, Mass. — – Gen9, Inc., a pioneer in the development of scalable technologies for synthesizing and assembling DNA, today announced that it is now accepting entries for the annual G-Prize contest. For the first time, the G-Prize contest is also open to pre-commercial start-up companies. The G-Prize contest, conceived and exclusively-sponsored by Gen9, was […]
AMSBIO has signed a strategic marketing agreement with Luxcel Biosciences to distribute their range of 96- and 384-well phosphorescence and fluorescence based assays. These new assay kits enable direct real-time analysis of Mitochondrial Respiration (MitoXpress® Xtra), Glycolysis (pH-Xtra®) and Intracellular Oxygen Concentration (MitoXpress® Intra) – providing the perfect tool kit for monitoring bioenergentics, metabolism, Warburg […]
ROCKY HILL, Conn. -– Connecticut Innovations (CI), the leading source of financing and ongoing support for Connecticut’s innovative, growing companies, today announced that Bio-Techne, a company engaged in the development, manufacture and sale of biotechnology products and clinical calibrators and controls, successfully completed the acquisition of a CI portfolio company, CyVek. Connecticut Innovations invested approximately […]
LUND, Sweden — The Board of Directors of Genovis has announced that it has filed a lawsuit against Promega Corporation (“Promega”) for patent infringement regarding one of Promega’s products. The lawsuit includes an injunction to prevent Promega from producing, using, selling or offering for sale the infringing product, as well as damages. The suit was […]
SEATTLE — ReachBio Research Labs (a registered trade name of ReachBio LLC, Seattle, WA) announced today that it has signed an agreement with Funakoshi Co., Ltd. (Tokyo, Japan), giving Funakoshi non-exclusive distribution rights to ReachBio’s human primary cell product line for the life science research market within Japan. Under a companion agreement, Funakoshi will also […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
